# Spartan Bioscience Inc.

Organization · id `cardio:org-spartan-bioscience-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Spartan+Bioscience+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Spartan Bioscience Inc.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (`cardio:ct-nct01184300`)
- Sponsors: Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (`cardio:ct-nct01452139`)
- Sponsors: Tailored Antiplatelet Therapy Following PCI (`cardio:ct-nct01742117`)

## Provenance

Content hash: 2540e8127e7ce0b6f7dc4aee958c04d9a2acf7e232395a6ace4a75334d1843a5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
